Table 1. Results of a review of the empirical literature on P. aeruginosa siderophore mutants and cheating.
Reference | Producer strain | Non-producer strain | Growth medium | Specific test for cooperation | Location of results in publication | Non-producer start frequency | Cheating observed? | Notes |
---|---|---|---|---|---|---|---|---|
Griffin et al., 2004 | ATCC 15692 (PAO1) | PA06609 (PAO9) | CAA+apotransferrin | Yes | Text | 0.5 | Variable | Cheating was concluded on the basis of differences in density of pure vs mixed culture, relative fitness not reported. |
Harrison et al., 2006 | ATCC 15692 (PAO1) | PA06609 (PAO9) | Waxworm | Yes | Figures 3 and 4 | 0.03–0.9 | No | Highest reported cheat relative fitness is 1, at start frequencies⩽0.01 |
Ross-Gillespie et al., 2007 | ATCC 15692 (PAO1) | PA06609 (PAO9) | CAA+apotransferrin | Yes | Figure 3 | 0.001–0.99 | Variable | Cheating observed at starting frequencies⩽0.1; total population density only affected at lowest start frequency |
Ross-Gillespie et al., 2007 | ATCC 15692 (PAO1) | PAO1 ΔpvdD | CAA+apotransferrin | Yes | Figure 3 | 0.001–0.99 | Variable | Cheating observed at starting frequencies of 0.001, but no effect on total population density. This mutant gains less fitness benefit from co-culture than PAO9 does |
Ross-Gillespie et al., 2007 | UCBPP-PA14 (clinical) | Spontaneous mutant | CAA+apotransferrin | Yes | Figure 3 | 0.001–0.99 | Variable | Cheating observed at start frequencies⩽0.1, but no effects on total population density. This mutant gains less fitness benefit from co-culture than PAO9 does |
Harrison et al., 2008 | PAO985 | De novo evolution experiment | CAA+apotransferrin/iron,±S. aureus | No | Figures 1 and 2 | 0 | ||
Brockhurst et al., 2008 | ATCC 15692 (PAO1) | PA06609 (PAO9) | M9 minimal salts+CAA+apotransferrin | No, but raw data available | Figure 4 & raw data | 0.5 | Yes | Cheat relative fitness in mixed culture decreases as more resources are supplied to the media (CAA concentration manipulated to alter carbohydrate and amino acid supply) |
Kümmerli et al., 2009a | ATCC 15692 (PAO1) | PA06609 (PAO9) | CAA+apotransferrin | Yes | Text | 0.33 | Yes | |
Kümmerli et al., 2009b | ATCC 15692 (PAO1) | PAO1 ΔpvdD | CAA+apotransferrin | No | ||||
Kümmerli et al., 2009b | ATCC 15692 (PAO1) | PAO1 ΔpvdD/ΔpchEF | CAA+apotransferrin | Yes | Figure 4 | 0.17–0.83 | Yes | Cheat is always fitter than the wild type, even when competed at a starting frequency of 0.83. |
Kümmerli et al., 2009c | ATCC 15692 (PAO1) | PA06609 (PAO9) | CAA+apotransferrin | Yes | Figure 2 | 0.33 | Variable | Cheating is time dependent |
Harrison and Buckling, 2009 | ATCC 15692 (PAO1) | pvdF transposon mutant in MPAO1 background (PA2396-C04::ISlacZ/hah) | CAA+apotransferrin | No, but raw data available | Raw data | 0.5 | No | Re-analysis of raw data reveals this mutant is less fit then the wild type in mixtures with a starting frequency of 0.5 in planktonic and biofilm culture. |
Harrison and Buckling, 2009 | ATCC 15692 (PAO1) | Clones evolved from PAO6049 | CAA+apotransferrin | No | Raw data | 0.5 | No | Mutants outcompete the wild type in planktonic mixed culture, but so does their siderophore-pruducing ancestor & they are lab adapted, growing as well as PAO1 in pure culture. |
Ross-Gillespie et al., 2009 | ATCC 15692 (PAO1) | PA06609 (PAO9) | CAA+apotransferrin | Yes | Figure 2 | 0.09 | No | |
Ross-Gillespie et al., 2009 | ATCC 15692 (PAO1) | PAO1 ΔpvdD | CAA+apotransferrin | Yes | Figure 2 | 0.09 | Variable | Cheating observed at high cell density only. |
Ross-Gillespie et al., 2009 | UCBPP-PA14 (clinical isolate) | Spontaneous mutant | CAA+apotransferrin | Yes | Figure 2 | 0.09 | Variable | Cheating observed at high cell density only. |
Kümmerli et al., 2010 | ATCC 15692 (PAO1) | PA06609 (PAO9) | CAA+apotransferrin | Yes | Text | 0.5 | Yes | |
Kümmerli and Brown, 2010 | ATCC 15692 (PAO1) | PAO1 ΔpvdD | CAA+apotransferrin | Yes | Figure 5 | 0.5 | Yes | |
Kümmerli and Brown, 2010 | PAO6049 | PA06609 (PAO9) | CAA+apotransferrin | No | ||||
Kümmerli and Brown, 2010 | Environmental isolate | Spontaneous mutant | CAA+apotransferrin | Yes | Figure 5 | 0.5 | Yes | |
Jiricny et al., 2010 | ATCC 15692 (PAO1) | PAO1 ΔpvdD | CAA+apotransferrin | Yes | Figures 4 and 5 | 0.09 | Yes | |
Jiricny et al., 2010 | ATCC 15692 (PAO1) | PAO1 ΔpchEF | CAA+apotransferrin | No | 0.09 | |||
Jiricny et al., 2010 | ATCC 15692 (PAO1) | PAO1 ΔpvdD/ΔpchEF | CAA+apotransferrin | No | 0.09 | |||
Jiricny et al., 2010 | 11 various isolates | Spontaneous mutants | CAA+apotransferrin | Yes | Figures 4 and 5 | 0.09 | Variable | Cheating observed for 8/11mutants. Three non-cheats (with high pyoverdin production) may be driving the reported trend. |
Harrison and Buckling, 2011 | PAO6049 | Evolved clones | CAA+apotransferrin | Yes | Figure 1 | 0.05, 0.5 | Variable | Cheating observed at low starting frequencies for a minority of mutants (mean relative fitness=1) |
Harrison and Buckling, 2011 | PAO1 ΔmutS | Evolved clones | CAA+apotransferrin | Yes | Figure 1 | 0.05, 0.5 | Variable | Cheating observed at low starting frequencies only for a majority of mutants, but some can cheat from a starting frequency of 0.5. |
Dumas and Kümmerli, 2012 | ATCC 15692 (PAO1) | Evolved clones | CAA+apotransferrin | No | Figures 3 and 4 | 0 | Pyoverdine-deficient clones evolved, but their presence did not consistently reduce population growth—some were associated with increased growth. | |
Dumas et al., 2013 | ATCC 15692 (PAO1) | PAO1 ΔpvdD and ΔpvdD/ΔpchEF | CAA+apotransferrin | No | Figure 4 | Three-strain mix, each strain at 0.33 | Carbon source, pH and temperature determine the relative growth advantage conferred by siderophores in monoculture. In acidic pH, ΔpvdD grows better. Report outcome of simuated competitions based on monoculture growth parameters. | |
Ghoul et al., 2014 | Cystic fibrosis isolate | 2x spontaneous mutants | CAA | Yes | Figures 3 and 4 | 0.1 | Yes | Mutant with reduced pyoverdine production cheats on parent strain, and is cheated on by a second spontaneous mutant with even lower pyoverdine production. |
Ross-Gillespie et al., 2015 | PAO1 ΔpvdD | PAO1 ΔpvdD/ΔpchEF | CAA+apotransferrin | Yes | Figure 2 | 0.2 | Yes | This experiment competed a double pyoverdine/pyochelin knockouts against a single pyoverdine knockout. |
Ross-Gillespie et al., 2015 | PAO1 ΔpchEF | PAO1 ΔpvdD/ΔpchEF | CAA+apotransferrin | Yes | Figure 2 | 0.2 | Yes | This experiment competed a double pyoverdine/pyochelin knockouts against a single pyochelin knockout. |
Kümmerli et al., 2015 | ATC 15692 (PAO1) | PAO1 ΔpvdD | CAA+apotransferrin | No, but can be inferred from data supplied | Figures 1,2,3 | 0.5 | Yes | There is a coevolutionary arms race, whereby producers become less exploitable and non-producers become better cheats. Non-producer frequency is negatively correlated with population growth. Non-producers grow less well than producers in monoculture, and contemporary pairs show relative fitness of non-producers is >1 (though graphs suggest this effect is small). |
Andersen et al., 2015 | Cystic fibrosis isolates | CF isolates | No culture | No | Text | Cheating inferred by sequence of mutations affecting pyoverdine production and uptake. Very few mutations reported in pyoverdine biosynthetic loci and none pyochelin loci. Most mutations are in pvdS. | ||
Ghoul et al., 2016 | ATCC 15692 (PA01) | PA06609 (PAO9) | CAA+apotransferrin | Yes | Figures 1a and 2a | 0.02–0.10 | Variable | Mutant cheats only if added to producer cultures before the onset of stationary phase. |
Leinweber et al., 2017 | ATCC 15692 (PA01)+eGFP tag | PAO1 ΔpvdD/ΔpchEF+mCherry tag. | CAA±apotransferrin | Yes | Figures 1,2c and 3,Supplementary Figure S1 | 0.1, 0.5, 0.9 | Yes | Mutant was fitter than the wild type in shaken liquid medium (no spatial structure) and as fit as the wild type in static medium or medium solidified with agar (spatial structure present) when apotransferrin was added, regardless of starting frequency. No cheating observed when apotransferrin was not added. |
Vasse et al., 2017 | ATCC 15692 (PA01) | PAO1 ΔpvdD | CAA+apotransferrin | Yes | Supplementary Figure S1 and Figure 1 | 0.15, 0.45, 0.75 | Yes | When progressively higher concentrations of gentamicin are added to the medium, mutants lose their growth disadvanatge in monoculture but gain a larger benefit from co-culture with the wild type. |
Abbreviation: CAA, casamino acids medium.